During chronic myeloid lymphocytic leukemia (CML), the transcription factors SP1 and EGR1 bind to the FYN promoter, which reduces FYN expression [18]. This evidence concerns the gene FYN and chronic myelogenous leukemia, BCR-ABL1 positive.